Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Tetra Bio-Pharma hopes $6M raise carries firm through to revenue stage
Orléans-based company has spent years developing drugs designed to mimic the pain-killing and anti-inflammatory benefits of cannabis without major side effects.
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored
What about the First Home Savings Account?
10 essential considerations when selling your business
EVENT ALERT: Mayor's Breakfast with Ontario Finance Minister on Wednesday, Dec. 4 @ City Hall